National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Liver Cirrhosis trials

The registry lists 11 Liver Cirrhosis studies with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 1Phase 2 4Phase 3 5No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesRecruitingNCT05832229Phase 2
• New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis CCompletedNCT01888900Phase 2Results posted
• Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard TreatmentCompletedNCT00006164Phase 3Results posted
• Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic FibrosisCompletedNCT01144507
• SAMe to Treat Biliary Cirrhosis SymptomsTerminatedNCT00125281Phase 2
• Treatment of Cholestatic Pruritus With SertralineCompletedNCT00058903Phase 2
• Prevention of Esophageal Varices by Beta-Adrenergic BlockersCompletedNCT00006398Phase 3
• Ursodiol-Methotrexate for Primary Biliary CirrhosisCompletedNCT00006168Phase 3
• North American Study for the Treatment of Refractory Ascites (NASTRA)CompletedNCT00006166Phase 3
• Decompression Intervention of Variceal Rebleeding Trial (DIVERT)CompletedNCT00006161Phase 3
• Pilot Study of Budesonide for Patients With Primary Sclerosing CholangitisCompletedNCT00004842Phase 1